Yorvipath multiple strengths Images
Generic Name: palopegteriparatide
This medication has been identified as Yorvipath multiple strengths. It is supplied by Ascendis Pharma, Inc.
Yorvipath is used in the treatment of Hypoparathyroidism and belongs to the drug class parathyroid hormone and analogs. Yorvipath multiple strengths is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Yorvipath
- Generic Name
- palopegteriparatide
- Strength
- multiple strengths
- Availability
- Prescription only
- Drug Class
- Parathyroid hormone and analogs
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ascendis Pharma, Inc.
- National Drug Code (NDC)
- multiple
See also:
Natpara
Natpara (parathyroid hormone) is used to treat hypocalcemia in patients with hypoparathyroidism ...
Drisdol
Drisdol is used for familial hypophosphatemia, hypocalcemia, hypoparathyroidism, hypophosphatemia ...
Rocaltrol
Rocaltrol is used for hypocalcemia, hypoparathyroidism, renal osteodystrophy, rickets, secondary ...
Calciferol
Calciferol is used for familial hypophosphatemia, hypocalcemia, hypoparathyroidism ...
More about Yorvipath (palopegteriparatide)
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: parathyroid hormone and analogs
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.